Protecting the Cold Chain - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Protecting the Cold Chain
Makers of temperature-sensitive products constantly seek to ensure proper conditions during shipping and storage.


Pharmaceutical Technology


Temperature-sensitive shipments typically include wet ice, dry ice, or gel packs to help maintain refrigerated or frozen conditions inside the container. Wet ice is messy, and dry ice can be dangerous because it can burn exposed skin. All three traditional refrigerant options are relatively heavy and offer no cooling action once thawed. More active cooling is available from a gel-equipped fabric that is conditioned with water and frozen before packing in a process that can be automated for high-volume requirements. An active polymer in the gel holds water in suspension for 6–8 days and stays frozen for 25% longer than an equal mass in a gel pack. Even after thawing, the water sublimes through the fabric and continues to provide evaporative cooling to maintain safe product temperatures for twice as long as traditional refrigerants. The flat, flexible fabric also distributes cold more evenly through the container than wet ice, dry ice, or gel packs ("ThermaFreeze" refrigerant pads, ThermaFreezeProducts Corp., Theo-dore, AL).

Hallie Forcinio is Pharmaceutical Technology's Packaging Forum editor, 4708 Morningside Drive, Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,
.

Company websites

The following is a list of websites for the companies mentioned in this column:
AeroScout, Inc., http://www.aeroscout.com/
Ceebron Pty. Limited, http://www.smart-trace.com/
Cold Chain Technologies, http://www.coldchaintech.com/
Coldkeepers, LLC, http://www.koldtogo.com/
Cryolog, http://www.cryolog.com/
DHL, http://www.dhl.com/
double u products, Inc., http://www.howmanydaysago.com/
Elpro Services Inc., http://www.elpro.com/
Harald H. Temmel KEG, http://www.temmel-austria.com/
Information Mediary Corp., http://www.log-ic.biz/
International Safe Transit Association, http://www.ista.org/
Microlise, http://www.microlise.com/
Minnesota Thermal Science, http:// http://goldenhourtechnology.com/
R.N.C. Industries, Inc., http://www.rncinc.com/
Schreiner MediPharm, http://www.schreiner-medipharm.de/
SecureRF, http://www.securerf.com/
Sensaphone, Inc., http://www.sensaphone.com/
Talecris Biotherapeutics, Inc. http://www.talecris.com/
TCP Reliable, http://www.tcpreliable.com/
Termika US, http://www.termika.us/
ThermaFreezeProducts Corp. http://www.thermafreeze.com/
Timestrip plc, http://www.timestrip.com/


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
18%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here